Sele was upregulated in ECs from eight disease models including CCM, EAE, stroke, TBI, epilepsy, AOD, diabetic nephropathy, Alport syndrome, and NASH, highlighting the broad role of Sele in multiple disease progressions (Silva et al., 2017). The gene discussed is SELE; the disease is metabolic dysfunction-associated steatohepatitis.